Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1975 Aug 2;3(5978):278–281. doi: 10.1136/bmj.3.5978.278

Evidence of gentamicin nephrotoxicity in patients with renal allografts.

J M Wellwood, P M Simpson, J R Tighe, A E Thompson
PMCID: PMC1674189  PMID: 1097045

Abstract

Renal damage was assessed by measuring urinary enzyme excretion in 180 patients with renal allografts. Thirty-six of these patients were studied during 53 courses of treatment with antimicrobial agents which was the only antimicrobial agent which was associated with an increase in urinary enzyme activity. There was usually also evidence of reduced renal function. Renal morphological changes similar to those produced by gentamicin in rats were observed in human allograft biopsy specimens obtained during gentamicin treatment.

Full text

PDF
278

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcieri G. M., Falco F. G., Smith H. M., Hobson L. B. Clinical research experience with gentamicin. Incidence of adverse reactions. Med J Aust. 1970 Jun 13;1(Suppl):30–34. [PubMed] [Google Scholar]
  2. BLACK J., CALESNICK B., WILLIAMS D., WEINSTEIN M. J. PHARMACOLOGY OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC. Antimicrob Agents Chemother (Bethesda) 1963;161:138–147. [PubMed] [Google Scholar]
  3. Brogard J. M., Conraux C., Collard M., Stahl J., Greiner G. F., Lavillaureix J. Tolérance rénale et cochleo-vestibulaire de la gentamicine. Etude comparative chez des sujets à fonction rénale normale et altérée. Therapeutique. 1970 Jun-Jul;46(6):627–638. [PubMed] [Google Scholar]
  4. Cox C. E. Gentamicin, a new aminoglycoside antibiotic: clinical and laboratory studies in urinary tract infection. J Infect Dis. 1969 Apr-May;119(4):486–491. doi: 10.1093/infdis/119.4-5.486. [DOI] [PubMed] [Google Scholar]
  5. Fernley H. N., Walker P. G. Kinetic behaviour of calf-intestinal alkaline phosphatase with 4-methylumbelliferyl phosphate. Biochem J. 1965 Oct;97(1):95–103. doi: 10.1042/bj0970095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jackson G. G. Current therapeutics. 234. Gentamicin. Practitioner. 1967 Jun;198(188):855–866. [PubMed] [Google Scholar]
  7. Kahn T., Stein R. M. Gentamicin and renal failure. Lancet. 1972 Feb 26;1(7748):498–498. doi: 10.1016/s0140-6736(72)90165-1. [DOI] [PubMed] [Google Scholar]
  8. Kleinknecht D., Ganeval D., Droz D. Acute renal failure after high doses of gentamicin and cephalothin. Lancet. 1973 May 19;1(7812):1129–1129. doi: 10.1016/s0140-6736(73)90447-9. [DOI] [PubMed] [Google Scholar]
  9. Kosek J. C., Mazze R. I., Cousins M. J. Nephrotoxicity of gentamicin. Lab Invest. 1974 Jan;30(1):48–57. [PubMed] [Google Scholar]
  10. LEABACK D. H., WALKER P. G. Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J. 1961 Jan;78:151–156. doi: 10.1042/bj0780151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leigh D. A. Treatment of gram-negative infections in patients before and after renal transplantation. Postgrad Med J. 1969 Apr;45(522):254–260. doi: 10.1136/pgmj.45.522.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Opitz A., Herrmann I., van Herrath D., Schaefer K. Akute Niereninsuffizienz nach Gentamycin-Cephalosporin-Kombinationstherapie. Med Welt. 1971 Mar 13;11:434–438. [PubMed] [Google Scholar]
  13. Robinson D., Price R. G., Dance N. Separation and properties of beta-galactosidase, beta-glucosidase, beta-glucuronidase and N-acetyl-beta-glucosaminidase from rat kidney. Biochem J. 1967 Feb;102(2):525–532. doi: 10.1042/bj1020525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sandman R., Margules R. M., Kountz S. L. Urinary lysosomal glycosidases after renal allotransplantation: correlation of enzyme excretion with allograft rejection and ischemia. Clin Chim Acta. 1973 May 30;45(4):349–359. doi: 10.1016/0009-8981(73)90035-1. [DOI] [PubMed] [Google Scholar]
  15. Taguchi Y., Siddiquie N. Gentamicin and kidney transplantation: an assessment in vitro and in vivo. J Urol. 1972 Jun;107(6):911–916. doi: 10.1016/s0022-5347(17)61170-4. [DOI] [PubMed] [Google Scholar]
  16. Top F. H., Jr, Grossman R. A., Bartelloni P. J., Segal H. E., Dudding B. A., Russell P. K., Buescher E. L. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis. 1971 Aug;124(2):148–154. doi: 10.1093/infdis/124.2.148. [DOI] [PubMed] [Google Scholar]
  17. WEINSTEIN M. J., LUEDEMANN G. M., ODEN E. M., WAGMAN G. H., ROSSELET J. P., MARQUEZ J. A., CONIGLIO C. T., CHARNEY W., HERZOG H. L., BLACK J. GENTAMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA. J Med Chem. 1963 Jul;6:463–464. doi: 10.1021/jm00340a034. [DOI] [PubMed] [Google Scholar]
  18. Wellwood J. M., Ellis B. G., Hall J. H., Robinson D. R., Thompson A. E. Early warning of rejection? Br Med J. 1973 May 5;2(5861):261–265. doi: 10.1136/bmj.2.5861.261. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES